Insider Trading › NTLA › Insiders
Intellia Therapeutics, Inc.
NTLA·Nasdaq·
United States·Insider activity
United States·Insider activity$12.37
-0.38 (-2.98%)
Close · Oct 6, 2026 · Close Prices from Tiingo.com
NTLA
Insider purchases and sales on the price
Nasdaq 100S&P 500
Filings
Default90D1Y5YALL
NTLAS&P 500 (rebased)
Insider BuyInsider SellForm 144 · planned sale
Loading price history…
Daily closes, adjusted for splits and dividends · Close Prices from Tiingo.comHover a marker, every one is a filing · move across the line for the crosshair
In the last 180 days, NTLA insiders filed 0 purchases ($0) and 6 sales ($530K) on the open market, by 3 insiders. Newest filing Oct 6, 2026 (yesterday).
Net Insider Buying by Quarter
Shares bought (+) or sold (−) on the open market by NTLA insiders · Form 4 · last two years
On Record
$0Purchases · 180 days
$530KSales · 180 days
298Open-market transactions on record
3Insiders filing · 180 days
Purchases (code P) and sales (code S) of NTLA common stock reported on Form 4, with Form 5 annual catch-ups. Grants, option exercises, gifts and tax withholding are not shown. Dollars are shares × the stated price; a price outside anything the stock traded at that day is withheld (n/c).
Insider Transactions
298 on record · newest trade first
AllPurchasesSalesOfficers & directors
| Insider | Type | Shares | Price | Value | Held after | Traded | Filed | |
|---|---|---|---|---|---|---|---|---|
| Dube Michael PVP, Chief Accounting Officer | Sale | −1,864 | $12.43 | $23K | 65.0Kdirect | Oct 2, 2026 | Oct 6, 2026 | Form 4 ↗ |
| LEONARD JOHN MPresident and CEO · Director | Sale | −2,785 | $13.00 | $36K | 1.1Mdirect | Aug 21, 2026 | Aug 24, 2026 | Form 4 ↗ |
| LEONARD JOHN MPresident and CEO · Director | Sale | −19.9K | $12.60 | $251K | 1.1Mdirect | Aug 20, 2026 | Aug 24, 2026 | Form 4 ↗ |
| Dulac Edward J IIIEVP, Chief Financial Officer | Sale | −8,111 | $11.25 | $91K | 148.2Kdirect | Jul 22, 2026 | Jul 24, 2026 | Form 4 ↗ |
| Dulac Edward J IIIEVP, Chief Financial Officer | Sale | −4,677 | $18.00 | $84K | 156.3Kdirect | Jul 2, 2026 | Jul 6, 2026 | Form 4 ↗ |
| Dube Michael PVP, Chief Accounting Officer | Sale | −2,641 | $16.78 | $44K | 66.9Kdirect | Jul 1, 2026 | Jul 6, 2026 | Form 4 ↗ |
| BASTA JAMESEVP, General Counsel | Sale | −1,211 | $13.78 | $17K | 156.8Kdirect | Mar 2, 2026 | Mar 3, 2026 | Form 4 ↗ |
| Clark ElianaEVP, Chief Technical Officer | Sale | −607 | $13.78 | $8K | 93.9Kdirect | Mar 2, 2026 | Mar 3, 2026 | Form 4 ↗ |
| LEONARD JOHN MPresident and CEO · Director | Sale | −34.1K | $9.21 | $314K | 1.0Mdirect | Jan 5, 2026 | Jan 7, 2026 | Form 4 ↗ |
| Schultes Birgit CEVP, Chief Scientific Officer | Sale | −8,508 | $9.21 | $78K | 98.5Kdirect | Jan 5, 2026 | Jan 7, 2026 | Form 4 ↗ |
| BASTA JAMESEVP, General Counsel | Sale | −10.4K | $9.21 | $96K | 101.5Kdirect | Jan 5, 2026 | Jan 7, 2026 | Form 4 ↗ |
| Cohen Fred EDirector | Purchase | +150.0K | $9.35 | $1.4M | 207.5Kdirect | Jan 5, 2026 | Jan 7, 2026 | Form 4 ↗ |
| Lebwohl DavidEVP, Chief Medical Officer | Sale | −11.9K | $9.21 | $110K | 121.2Kdirect | Jan 5, 2026 | Jan 7, 2026 | Form 4 ↗ |
| Clark ElianaEVP, Chief Technical Officer | Sale | −9,515 | $9.21 | $88K | 87.1Kdirect | Jan 5, 2026 | Jan 7, 2026 | Form 4 ↗ |
| Dulac Edward J IIIEVP, Chief Financial Officer | Sale | −6,379 | $9.21 | $59K | 99.7Kdirect | Jan 5, 2026 | Jan 7, 2026 | Form 4 ↗ |
| Dube Michael PVP, Chief Accounting Officer | Sale | −2,989 | $9.21 | $28K | 52.3Kdirect | Jan 5, 2026 | Jan 7, 2026 | Form 4 ↗ |
| LEONARD JOHN MPresident and CEO · Director | Sale | −5,355 | $9.59 | $51K | 1.0Mdirect | Dec 11, 2025 | Dec 12, 2025 | Form 4 ↗ |
| LEONARD JOHN MPresident and CEO · Director | Sale | −32.8K | $9.47 | $311K | 1.0Mdirect | Dec 11, 2025 | Dec 12, 2025 | Form 4 ↗ |
| LEONARD JOHN MPresident and CEO · Director | Sale | −50.0K | $9.49 | $474K | 1.1Mdirect | Dec 11, 2025 | Dec 12, 2025 | Form 4 ↗ |
| Schultes Birgit CEVP, Chief Scientific Officer | Sale | −31 | $17.38 | $539 | 105.2Kdirect | Oct 1, 2025 | Oct 3, 2025 | Form 4 ↗ |
| Dube Michael PVP, Chief Accounting Officer | Sale | −1,871 | $17.38 | $33K | 55.3Kdirect | Oct 1, 2025 | Oct 3, 2025 | Form 4 ↗ |
| CHASE WILLIAM JDirector | Purchase | +100.0K | $10.03 | $1.0M | 134.7Kdirect | Aug 20, 2025 | Aug 22, 2025 | Form 4 ↗ |
| Dulac Edward J IIIEVP, Chief Financial Officer | Sale | −7,462 | $14.02 | $105K | 106.1Kdirect | Jul 23, 2025 | Jul 25, 2025 | Form 4 ↗ |
| Dube Michael PVP, Chief Accounting Officer | Sale | −2,503 | $9.95 | $25K | 57.1Kdirect | Jul 2, 2025 | Jul 3, 2025 | Form 4 ↗ |
| Clark ElianaEVP, Chief Technical Officer | Sale | −1,022 | $9.82 | $10K | 95.4Kdirect | Jul 1, 2025 | Jul 3, 2025 | Form 4 ↗ |
| GOODMAN JESSEDirector | Sale | −1,547 | $9.23 | $14K | 24.4Kdirect | Jul 1, 2025 | Jul 2, 2025 | Form 4 ↗ |
| GOODMAN JESSEDirector | Sale | −1,547 | $9.56 | $15K | 25.9Kdirect | Jun 30, 2025 | Jul 2, 2025 | Form 4 ↗ |
| Bhanji MunaDirector | Sale | −265 | $8.50 | $2K | 19.2Kdirect | Apr 29, 2025 | May 1, 2025 | Form 4 ↗ |
| Clark ElianaEVP, Chief Technical Officer | Sale | −679 | $8.99 | $6K | 95.4Kdirect | Mar 4, 2025 | Mar 4, 2025 | Form 4 ↗ |
| BASTA JAMESEVP, General Counsel | Sale | −2,572 | $8.99 | $23K | 111.9Kdirect | Mar 4, 2025 | Mar 4, 2025 | Form 4 ↗ |
| Bhanji MunaDirector | Sale | −265 | $9.97 | $3K | 19.5Kdirect | Jan 29, 2025 | Jan 31, 2025 | Form 4 ↗ |
| Dube Michael PVP, Chief Accounting Officer | Sale | −1,372 | $12.18 | $17K | 45.6Kdirect | Jan 3, 2025 | Jan 7, 2025 | Form 4 ↗ |
| BASTA JAMESEVP, General Counsel | Sale | −7,074 | $12.18 | $86K | 74.5Kdirect | Jan 3, 2025 | Jan 7, 2025 | Form 4 ↗ |
| Lebwohl DavidEVP, Chief Medical Officer | Sale | −9,557 | $12.18 | $116K | 87.7Kdirect | Jan 3, 2025 | Jan 7, 2025 | Form 4 ↗ |
| Hicks DerekEVP, Chief Business Officer | Sale | −6,502 | $12.18 | $79K | 59.9Kdirect | Jan 3, 2025 | Jan 7, 2025 | Form 4 ↗ |
| LEONARD JOHN MPresident and CEO · Director | Sale | −26.8K | $12.18 | $327K | 941.1Kdirect | Jan 3, 2025 | Jan 7, 2025 | Form 4 ↗ |
| Sepp-Lorenzino LauraEVP, Chief Scientific Officer | Sale | −8,966 | $12.18 | $109K | 77.4Kdirect | Jan 3, 2025 | Jan 7, 2025 | Form 4 ↗ |
| Clark ElianaEVP, Chief Technical Officer | Sale | −7,422 | $12.18 | $90K | 64.0Kdirect | Jan 3, 2025 | Jan 6, 2025 | Form 4 ↗ |
| Clark ElianaEVP, Chief Technical Officer | Sale | −556 | $12.03 | $7K | 71.5Kdirect | Jan 2, 2025 | Jan 6, 2025 | Form 4 ↗ |
| Dube Michael PVP, Chief Accounting Officer | Sale | −2,012 | $19.01 | $38K | 47.0Kdirect | Oct 2, 2024 | Oct 4, 2024 | Form 4 ↗ |
| Clark ElianaEVP, Chief Technical Officer | Sale | −405 | $22.93 | $9K | 71.5Kdirect | Jul 1, 2024 | Jul 3, 2024 | Form 4 ↗ |
| Verwiel FrankDirector | Sale | −1,505 | $25.00 | $38K | 17.9Kdirect | Jun 17, 2024 | Jun 20, 2024 | Form 4 ↗ |
| BASTA JAMESEVP, General Counsel | Sale | −2,297 | $32.99 | $76K | 81.6Kdirect | Mar 4, 2024 | Mar 5, 2024 | Form 4 ↗ |
| Clark ElianaEVP, Chief Technical Officer | Sale | −605 | $32.99 | $20K | 71.5Kdirect | Mar 4, 2024 | Mar 5, 2024 | Form 4 ↗ |
| Sepp-Lorenzino LauraEVP, Chief Scientific Officer | Sale | −667 | $29.38 | $20K | 43.9Kdirect | Jan 8, 2024 | Jan 10, 2024 | Form 4 ↗ |
| Sepp-Lorenzino LauraEVP, Chief Scientific Officer | Sale | −1,608 | $28.66 | $46K | 44.6Kdirect | Jan 8, 2024 | Jan 10, 2024 | Form 4 ↗ |
| LEONARD JOHN MPresident and CEO · Director | Sale | −19.2K | $29.46 | $566K | 846.5Kdirect | Jan 3, 2024 | Jan 5, 2024 | Form 4 ↗ |
| Lebwohl DavidEVP, Chief Medical Officer | Sale | −5,843 | $29.46 | $172K | 54.4Kdirect | Jan 3, 2024 | Jan 5, 2024 | Form 4 ↗ |
| Sepp-Lorenzino LauraEVP, Chief Scientific Officer | Sale | −5,532 | $29.46 | $163K | 46.2Kdirect | Jan 3, 2024 | Jan 5, 2024 | Form 4 ↗ |
| Goddard GlennEVP, Chief Financial Officer | Sale | −5,365 | $29.46 | $158K | 40.6Kdirect | Jan 3, 2024 | Jan 5, 2024 | Form 4 ↗ |
| Hicks DerekEVP, Chief Business Officer | Sale | −3,877 | $29.46 | $114K | 37.0Kdirect | Jan 3, 2024 | Jan 5, 2024 | Form 4 ↗ |
| BASTA JAMESEVP, General Counsel | Sale | −3,805 | $29.46 | $112K | 51.5Kdirect | Jan 3, 2024 | Jan 5, 2024 | Form 4 ↗ |
| Clark ElianaEVP, Chief Technical Officer | Sale | −4,301 | $29.46 | $127K | 40.8Kdirect | Jan 3, 2024 | Jan 5, 2024 | Form 4 ↗ |
| Clark ElianaEVP, Chief Technical Officer | Sale | −307 | $30.12 | $9K | 45.1Kdirect | Jan 3, 2024 | Jan 5, 2024 | Form 4 ↗ |
| Bhanji MunaDirector | Sale | −265 | $23.90 | $6K | 12.0Kdirect | Oct 31, 2023 | Nov 2, 2023 | Form 4 ↗ |
| Bhanji MunaDirector | Sale | −265 | $42.33 | $11K | 12.3Kdirect | Jul 31, 2023 | Aug 2, 2023 | Form 4 ↗ |
| Bhanji MunaDirector | Sale | −1,867 | $39.30 | $73K | 12.5Kdirect | Jul 6, 2023 | Jul 10, 2023 | Form 4 ↗ |
| Clark ElianaEVP, Chief Technical Officer | Sale | −360 | $40.51 | $15K | 45.1Kdirect | Jul 3, 2023 | Jul 6, 2023 | Form 4 ↗ |
| Clark ElianaEVP, Chief Technical Officer | Sale | −5,000 | $45.00 | $225K | 45.1Kdirect | Jun 20, 2023 | Jun 22, 2023 | Form 4 ↗ |
| BASTA JAMESEVP, General Counsel | Sale | −1,088 | $43.88 | $48K | 55.3Kdirect | Mar 2, 2023 | Mar 3, 2023 | Form 4 ↗ |
| Sepp-Lorenzino LauraEVP, Chief Scientific Officer | Sale | −689 | $39.10 | $27K | 17.6Kdirect | Jan 5, 2023 | Jan 6, 2023 | Form 4 ↗ |
| Sepp-Lorenzino LauraEVP, Chief Scientific Officer | Sale | −1,641 | $38.22 | $63K | 18.3Kdirect | Jan 5, 2023 | Jan 6, 2023 | Form 4 ↗ |
| Sepp-Lorenzino LauraEVP, Chief Scientific Officer | Sale | −2,508 | $37.21 | $93K | 20.0Kdirect | Jan 4, 2023 | Jan 6, 2023 | Form 4 ↗ |
| LEONARD JOHN MPresident and CEO · Director | Sale | −6,673 | $37.21 | $248K | 766.8Kdirect | Jan 4, 2023 | Jan 6, 2023 | Form 4 ↗ |
| Hicks DerekEVP, Chief Business Officer | Sale | −1,812 | $37.21 | $67K | 17.3Kdirect | Jan 4, 2023 | Jan 6, 2023 | Form 4 ↗ |
| Lebwohl DavidEVP, Chief Medical Officer | Sale | −2,574 | $37.21 | $96K | 25.7Kdirect | Jan 4, 2023 | Jan 6, 2023 | Form 4 ↗ |
| Goddard GlennEVP, Chief Financial Officer | Sale | −2,427 | $37.21 | $90K | 15.4Kdirect | Jan 4, 2023 | Jan 6, 2023 | Form 4 ↗ |
| Clark ElianaEVP, Chief Technical Officer | Sale | −1,692 | $37.21 | $63K | 14.5Kdirect | Jan 4, 2023 | Jan 6, 2023 | Form 4 ↗ |
| BASTA JAMESEVP, General Counsel | Sale | −1,138 | $37.21 | $42K | 19.6Kdirect | Jan 4, 2023 | Jan 6, 2023 | Form 4 ↗ |
| Clark ElianaEVP, Chief Technical Officer | Sale | −231 | $34.48 | $8K | 16.2Kdirect | Jan 3, 2023 | Jan 6, 2023 | Form 4 ↗ |
| Clark ElianaEVP, Chief Technical Officer | Sale | −105 | $51.74 | $5K | 16.2Kdirect | Jul 1, 2022 | Jan 6, 2023 | Form 4 ↗ |
| LEONARD JOHN MPresident and CEO · Director | Sale | −2,493 | $112.26 | $280K | 724.7Kdirect | Jan 1, 2022 | Mar 4, 2022 | Form 4 ↗ |
| Sepp-Lorenzino LauraEVP, Chief Scientific Officer | Sale | −1,148 | $112.25 | $129K | 4,815direct | Jan 1, 2022 | Mar 3, 2022 | Form 4 ↗ |
| Lebwohl DavidEVP, Chief Medical Officer | Sale | −1,051 | $112.24 | $118K | 10.9Kdirect | Jan 1, 2022 | Mar 3, 2022 | Form 4 ↗ |
| Goddard GlennEVP, Chief Financial Officer | Sale | −1,013 | $112.24 | $114K | 2,049direct | Jan 1, 2022 | Mar 3, 2022 | Form 4 ↗ |
| Lebwohl DavidEVP, Chief Medical Officer | Sale | −200 | $135.34 | $27K | 8,714direct | Nov 5, 2021 | Nov 9, 2021 | Form 4 ↗ |
| Lebwohl DavidEVP, Chief Medical Officer | Sale | −548 | $134.07 | $73K | 8,914direct | Nov 5, 2021 | Nov 9, 2021 | Form 4 ↗ |
| Lebwohl DavidEVP, Chief Medical Officer | Sale | −452 | $132.62 | $60K | 9,462direct | Nov 5, 2021 | Nov 9, 2021 | Form 4 ↗ |
| Lebwohl DavidEVP, Chief Medical Officer | Sale | −1,200 | $131.71 | $158K | 9,914direct | Nov 5, 2021 | Nov 9, 2021 | Form 4 ↗ |
| Lebwohl DavidEVP, Chief Medical Officer | Sale | −250 | $130.47 | $33K | 8,714direct | Oct 14, 2021 | Oct 15, 2021 | Form 4 ↗ |
| Lebwohl DavidEVP, Chief Medical Officer | Sale | −525 | $129.83 | $68K | 8,964direct | Oct 14, 2021 | Oct 15, 2021 | Form 4 ↗ |
| Lebwohl DavidEVP, Chief Medical Officer | Sale | −225 | $129.01 | $29K | 9,489direct | Oct 14, 2021 | Oct 15, 2021 | Form 4 ↗ |
| Lebwohl DavidEVP, Chief Medical Officer | Sale | −849 | $127.81 | $109K | 9,714direct | Oct 14, 2021 | Oct 15, 2021 | Form 4 ↗ |
| Lebwohl DavidEVP, Chief Medical Officer | Sale | −551 | $126.92 | $70K | 10.6Kdirect | Oct 14, 2021 | Oct 15, 2021 | Form 4 ↗ |
| Crowley John FDirector | Sale | −2,500 | $119.55 | $299K | 2,094direct | Oct 11, 2021 | Oct 13, 2021 | Form 4 ↗ |
| Crowley John FDirector | Sale | −200 | $132.84 | $27K | 2,094direct | Oct 5, 2021 | Oct 7, 2021 | Form 4 ↗ |
| Crowley John FDirector | Sale | −1,846 | $131.74 | $243K | 2,294direct | Oct 5, 2021 | Oct 7, 2021 | Form 4 ↗ |
| Crowley John FDirector | Sale | −3,759 | $130.92 | $492K | 4,140direct | Oct 5, 2021 | Oct 7, 2021 | Form 4 ↗ |
| Crowley John FDirector | Sale | −2,915 | $129.88 | $379K | 7,899direct | Oct 5, 2021 | Oct 7, 2021 | Form 4 ↗ |
| Crowley John FDirector | Sale | −1,280 | $128.83 | $165K | 10.8Kdirect | Oct 5, 2021 | Oct 7, 2021 | Form 4 ↗ |
| Lebwohl DavidEVP, Chief Medical Officer | Sale | −2,400 | $149.81 | $360K | 791direct | Sep 21, 2021 | Sep 23, 2021 | Form 4 ↗ |
| Goddard GlennEVP, Chief Financial Officer | Sale | −3,482 | $180.12 | $627K | 0direct | Sep 7, 2021 | Sep 9, 2021 | Form 4 ↗ |
| LEONARD JOHN MPresident and CEO · Director | Sale | −44.7K | $170.00 | $7.6M | 719.3Kdirect | Sep 1, 2021 | Sep 1, 2021 | Form 4 ↗ |
| LEONARD JOHN MPresident and CEO · Director | Sale | −37.8K | $155.00 | $5.9M | 719.3Kdirect | Aug 31, 2021 | Sep 1, 2021 | Form 4 ↗ |
| Goddard GlennEVP, Chief Financial Officer | Sale | −24.8K | $160.22 | $4.0M | 0direct | Aug 31, 2021 | Sep 1, 2021 | Form 4 ↗ |
| LEONARD JOHN MPresident and CEO · Director | Sale | −216 | $160.69 | $35K | 719.3Kdirect | Aug 30, 2021 | Sep 1, 2021 | Form 4 ↗ |
| LEONARD JOHN MPresident and CEO · Director | Sale | −725 | $159.98 | $116K | 719.5Kdirect | Aug 30, 2021 | Sep 1, 2021 | Form 4 ↗ |
| LEONARD JOHN MPresident and CEO · Director | Sale | −2,598 | $159.18 | $414K | 720.2Kdirect | Aug 30, 2021 | Sep 1, 2021 | Form 4 ↗ |
| LEONARD JOHN MPresident and CEO · Director | Sale | −3,123 | $157.75 | $493K | 722.8Kdirect | Aug 30, 2021 | Sep 1, 2021 | Form 4 ↗ |
| LEONARD JOHN MPresident and CEO · Director | Sale | −4,758 | $156.96 | $747K | 726.0Kdirect | Aug 30, 2021 | Sep 1, 2021 | Form 4 ↗ |
| LEONARD JOHN MPresident and CEO · Director | Sale | −15.6K | $155.70 | $2.4M | 730.7Kdirect | Aug 30, 2021 | Sep 1, 2021 | Form 4 ↗ |
| LEONARD JOHN MPresident and CEO · Director | Sale | −7,428 | $154.98 | $1.2M | 746.3Kdirect | Aug 30, 2021 | Sep 1, 2021 | Form 4 ↗ |
| LEONARD JOHN MPresident and CEO · Director | Sale | −2,334 | $153.66 | $359K | 753.7Kdirect | Aug 30, 2021 | Sep 1, 2021 | Form 4 ↗ |
| LEONARD JOHN MPresident and CEO · Director | Sale | −2,055 | $152.81 | $314K | 756.1Kdirect | Aug 30, 2021 | Sep 1, 2021 | Form 4 ↗ |
| Sepp-Lorenzino LauraEVP, Chief Scientific Officer | Sale | −207 | $160.47 | $33K | 2,391direct | Aug 30, 2021 | Sep 1, 2021 | Form 4 ↗ |
| Sepp-Lorenzino LauraEVP, Chief Scientific Officer | Sale | −2,653 | $159.64 | $424K | 2,598direct | Aug 30, 2021 | Sep 1, 2021 | Form 4 ↗ |
| Sepp-Lorenzino LauraEVP, Chief Scientific Officer | Sale | −1,515 | $158.90 | $241K | 5,251direct | Aug 30, 2021 | Sep 1, 2021 | Form 4 ↗ |
| Sepp-Lorenzino LauraEVP, Chief Scientific Officer | Sale | −3,932 | $157.77 | $620K | 6,766direct | Aug 30, 2021 | Sep 1, 2021 | Form 4 ↗ |
| Sepp-Lorenzino LauraEVP, Chief Scientific Officer | Sale | −7,425 | $156.79 | $1.2M | 10.7Kdirect | Aug 30, 2021 | Sep 1, 2021 | Form 4 ↗ |
| Sepp-Lorenzino LauraEVP, Chief Scientific Officer | Sale | −16.1K | $155.61 | $2.5M | 18.1Kdirect | Aug 30, 2021 | Sep 1, 2021 | Form 4 ↗ |
| Sepp-Lorenzino LauraEVP, Chief Scientific Officer | Sale | −28.7K | $154.77 | $4.4M | 34.2Kdirect | Aug 30, 2021 | Sep 1, 2021 | Form 4 ↗ |
| Sepp-Lorenzino LauraEVP, Chief Scientific Officer | Sale | −20.6K | $153.64 | $3.2M | 62.9Kdirect | Aug 30, 2021 | Sep 1, 2021 | Form 4 ↗ |
| Sepp-Lorenzino LauraEVP, Chief Scientific Officer | Sale | −15.8K | $152.75 | $2.4M | 83.6Kdirect | Aug 30, 2021 | Sep 1, 2021 | Form 4 ↗ |
| Lebwohl DavidEVP, Chief Medical Officer | Sale | −150 | $160.10 | $24K | 791direct | Aug 30, 2021 | Sep 1, 2021 | Form 4 ↗ |
| Lebwohl DavidEVP, Chief Medical Officer | Sale | −1,100 | $159.19 | $175K | 941direct | Aug 30, 2021 | Sep 1, 2021 | Form 4 ↗ |
| Lebwohl DavidEVP, Chief Medical Officer | Sale | −250 | $157.60 | $39K | 2,041direct | Aug 30, 2021 | Sep 1, 2021 | Form 4 ↗ |
| Lebwohl DavidEVP, Chief Medical Officer | Sale | −700 | $156.70 | $110K | 2,291direct | Aug 30, 2021 | Sep 1, 2021 | Form 4 ↗ |
| Lebwohl DavidEVP, Chief Medical Officer | Sale | −200 | $155.43 | $31K | 2,991direct | Aug 30, 2021 | Sep 1, 2021 | Form 4 ↗ |
| Goddard GlennEVP, Chief Financial Officer | Sale | −300 | $160.84 | $48K | 0direct | Aug 30, 2021 | Sep 1, 2021 | Form 4 ↗ |
| Goddard GlennEVP, Chief Financial Officer | Sale | −300 | $159.53 | $48K | 300direct | Aug 30, 2021 | Sep 1, 2021 | Form 4 ↗ |
| Goddard GlennEVP, Chief Financial Officer | Sale | −300 | $158.42 | $48K | 600direct | Aug 30, 2021 | Sep 1, 2021 | Form 4 ↗ |
| Goddard GlennEVP, Chief Financial Officer | Sale | −496 | $157.33 | $78K | 900direct | Aug 30, 2021 | Sep 1, 2021 | Form 4 ↗ |
| Goddard GlennEVP, Chief Financial Officer | Sale | −300 | $156.10 | $47K | 1,396direct | Aug 30, 2021 | Sep 1, 2021 | Form 4 ↗ |
| Goddard GlennEVP, Chief Financial Officer | Sale | −1,700 | $155.29 | $264K | 1,696direct | Aug 30, 2021 | Sep 1, 2021 | Form 4 ↗ |
| Goddard GlennEVP, Chief Financial Officer | Sale | −1,100 | $154.29 | $170K | 3,396direct | Aug 30, 2021 | Sep 1, 2021 | Form 4 ↗ |
| Goddard GlennEVP, Chief Financial Officer | Sale | −704 | $153.22 | $108K | 4,496direct | Aug 30, 2021 | Sep 1, 2021 | Form 4 ↗ |
| LEONARD JOHN MPresident and CEO · Director | Sale | −100 | $153.52 | $15K | 719.3Kdirect | Aug 23, 2021 | Aug 25, 2021 | Form 4 ↗ |
| LEONARD JOHN MPresident and CEO · Director | Sale | −8,165 | $153.08 | $1.2M | 719.4Kdirect | Aug 23, 2021 | Aug 25, 2021 | Form 4 ↗ |
| LEONARD JOHN MPresident and CEO · Director | Sale | −18.9K | $151.54 | $2.9M | 727.6Kdirect | Aug 23, 2021 | Aug 25, 2021 | Form 4 ↗ |
| LEONARD JOHN MPresident and CEO · Director | Sale | −5,963 | $152.30 | $908K | 719.3Kdirect | Aug 19, 2021 | Aug 20, 2021 | Form 4 ↗ |
| LEONARD JOHN MPresident and CEO · Director | Sale | −6,993 | $151.56 | $1.1M | 725.3Kdirect | Aug 19, 2021 | Aug 20, 2021 | Form 4 ↗ |
| LEONARD JOHN MPresident and CEO · Director | Sale | −9,726 | $150.46 | $1.5M | 732.3Kdirect | Aug 19, 2021 | Aug 20, 2021 | Form 4 ↗ |
| Lebwohl DavidEVP, Chief Medical Officer | Sale | −2,400 | $164.05 | $394K | 791direct | Aug 9, 2021 | Aug 11, 2021 | Form 4 ↗ |
| Goddard GlennEVP, Chief Financial Officer | Sale | −530 | $152.13 | $81K | 0direct | Aug 5, 2021 | Aug 6, 2021 | Form 4 ↗ |
| Goddard GlennEVP, Chief Financial Officer | Sale | −9,568 | $151.41 | $1.4M | 530direct | Aug 5, 2021 | Aug 6, 2021 | Form 4 ↗ |
| Goddard GlennEVP, Chief Financial Officer | Sale | −9,902 | $150.65 | $1.5M | 10.1Kdirect | Aug 5, 2021 | Aug 6, 2021 | Form 4 ↗ |
| Sepp-Lorenzino LauraEVP, Chief Scientific Officer | Sale | −126 | $141.63 | $18K | 2,391direct | Aug 4, 2021 | Aug 6, 2021 | Form 4 ↗ |
| Sepp-Lorenzino LauraEVP, Chief Scientific Officer | Sale | −4,054 | $140.73 | $571K | 2,517direct | Aug 4, 2021 | Aug 6, 2021 | Form 4 ↗ |
| Sepp-Lorenzino LauraEVP, Chief Scientific Officer | Sale | −2,772 | $139.85 | $388K | 6,571direct | Aug 4, 2021 | Aug 6, 2021 | Form 4 ↗ |
| Sepp-Lorenzino LauraEVP, Chief Scientific Officer | Sale | −4,419 | $138.78 | $613K | 9,343direct | Aug 4, 2021 | Aug 6, 2021 | Form 4 ↗ |
| Sepp-Lorenzino LauraEVP, Chief Scientific Officer | Sale | −6,344 | $137.72 | $874K | 13.8Kdirect | Aug 4, 2021 | Aug 6, 2021 | Form 4 ↗ |
| Sepp-Lorenzino LauraEVP, Chief Scientific Officer | Sale | −6,814 | $136.79 | $932K | 20.1Kdirect | Aug 4, 2021 | Aug 6, 2021 | Form 4 ↗ |
| Sepp-Lorenzino LauraEVP, Chief Scientific Officer | Sale | −1,471 | $135.47 | $199K | 26.9Kdirect | Aug 4, 2021 | Aug 6, 2021 | Form 4 ↗ |
| FORMELA JEAN FRANCOISDirector | Sale | −6,149 | $143.45 | $882K | 10.0Kindirect | Jun 28, 2021 | Jun 29, 2021 | Form 4 ↗ |
| FORMELA JEAN FRANCOISDirector | Sale | −13.6K | $142.88 | $1.9M | 16.1Kindirect | Jun 28, 2021 | Jun 29, 2021 | Form 4 ↗ |
| FORMELA JEAN FRANCOISDirector | Sale | −8,420 | $141.66 | $1.2M | 29.7Kindirect | Jun 28, 2021 | Jun 29, 2021 | Form 4 ↗ |
| FORMELA JEAN FRANCOISDirector | Sale | −8,027 | $140.80 | $1.1M | 38.1Kindirect | Jun 28, 2021 | Jun 29, 2021 | Form 4 ↗ |
| FORMELA JEAN FRANCOISDirector | Sale | −52.3K | $139.96 | $7.3M | 46.2Kindirect | Jun 28, 2021 | Jun 29, 2021 | Form 4 ↗ |
| FORMELA JEAN FRANCOISDirector | Sale | −4,201 | $138.58 | $582K | 98.5Kindirect | Jun 28, 2021 | Jun 29, 2021 | Form 4 ↗ |
| FORMELA JEAN FRANCOISDirector | Sale | −5,400 | $138.05 | $745K | 102.7Kindirect | Jun 28, 2021 | Jun 29, 2021 | Form 4 ↗ |
| FORMELA JEAN FRANCOISDirector | Sale | −3,033 | $137.01 | $416K | 108.1Kindirect | Jun 28, 2021 | Jun 29, 2021 | Form 4 ↗ |
| FORMELA JEAN FRANCOISDirector | Sale | −21.9K | $135.83 | $3.0M | 111.1Kindirect | Jun 28, 2021 | Jun 29, 2021 | Form 4 ↗ |
| FORMELA JEAN FRANCOISDirector | Sale | −30.8K | $134.86 | $4.2M | 133.0Kindirect | Jun 28, 2021 | Jun 29, 2021 | Form 4 ↗ |
| FORMELA JEAN FRANCOISDirector | Sale | −36.5K | $133.77 | $4.9M | 163.8Kindirect | Jun 28, 2021 | Jun 29, 2021 | Form 4 ↗ |
| FORMELA JEAN FRANCOISDirector | Sale | −56.2K | $132.77 | $7.5M | 200.3Kindirect | Jun 28, 2021 | Jun 29, 2021 | Form 4 ↗ |
| FORMELA JEAN FRANCOISDirector | Sale | −53.8K | $131.82 | $7.1M | 256.5Kindirect | Jun 28, 2021 | Jun 29, 2021 | Form 4 ↗ |
| FORMELA JEAN FRANCOISDirector | Sale | −66.5K | $130.79 | $8.7M | 310.4Kindirect | Jun 28, 2021 | Jun 29, 2021 | Form 4 ↗ |
| FORMELA JEAN FRANCOISDirector | Sale | −48.7K | $129.88 | $6.3M | 376.8Kindirect | Jun 28, 2021 | Jun 29, 2021 | Form 4 ↗ |
| FORMELA JEAN FRANCOISDirector | Sale | −56.3K | $128.77 | $7.2M | 425.6Kindirect | Jun 28, 2021 | Jun 29, 2021 | Form 4 ↗ |
| FORMELA JEAN FRANCOISDirector | Sale | −55.5K | $127.79 | $7.1M | 481.8Kindirect | Jun 28, 2021 | Jun 29, 2021 | Form 4 ↗ |
| FORMELA JEAN FRANCOISDirector | Sale | −26.0K | $127.02 | $3.3M | 537.4Kindirect | Jun 28, 2021 | Jun 29, 2021 | Form 4 ↗ |
| FORMELA JEAN FRANCOISDirector | Sale | −653 | $89.25 | $58K | 563.4Kindirect | Jun 14, 2021 | Jun 15, 2021 | Form 4 ↗ |
| FORMELA JEAN FRANCOISDirector | Sale | −13.3K | $88.70 | $1.2M | 564.0Kindirect | Jun 14, 2021 | Jun 15, 2021 | Form 4 ↗ |
| FORMELA JEAN FRANCOISDirector | Sale | −93.1K | $87.75 | $8.2M | 577.3Kindirect | Jun 14, 2021 | Jun 15, 2021 | Form 4 ↗ |
| FORMELA JEAN FRANCOISDirector | Sale | −47.4K | $86.73 | $4.1M | 670.4Kindirect | Jun 14, 2021 | Jun 15, 2021 | Form 4 ↗ |
| FORMELA JEAN FRANCOISDirector | Sale | −16.3K | $85.92 | $1.4M | 717.9Kindirect | Jun 14, 2021 | Jun 15, 2021 | Form 4 ↗ |
| FORMELA JEAN FRANCOISDirector | Sale | −1,875 | $85.98 | $161K | 734.2Kindirect | Jun 11, 2021 | Jun 15, 2021 | Form 4 ↗ |
| FORMELA JEAN FRANCOISDirector | Sale | −29.1K | $85.18 | $2.5M | 736.0Kindirect | Jun 11, 2021 | Jun 15, 2021 | Form 4 ↗ |
| FORMELA JEAN FRANCOISDirector | Sale | −4,513 | $85.43 | $386K | 765.1Kindirect | Apr 29, 2021 | Apr 30, 2021 | Form 4 ↗ |
| FORMELA JEAN FRANCOISDirector | Sale | −29.7K | $86.12 | $2.6M | 769.6Kindirect | Apr 28, 2021 | Apr 28, 2021 | Form 4 ↗ |
| FORMELA JEAN FRANCOISDirector | Sale | −102.2K | $85.40 | $8.7M | 799.4Kindirect | Apr 28, 2021 | Apr 28, 2021 | Form 4 ↗ |
| FORMELA JEAN FRANCOISDirector | Sale | −61.7K | $87.08 | $5.4M | 901.5Kindirect | Apr 27, 2021 | Apr 28, 2021 | Form 4 ↗ |
| FORMELA JEAN FRANCOISDirector | Sale | −68.8K | $86.41 | $5.9M | 963.2Kindirect | Apr 27, 2021 | Apr 28, 2021 | Form 4 ↗ |
| FORMELA JEAN FRANCOISDirector | Sale | −79.7K | $85.39 | $6.8M | 1.0Mindirect | Apr 27, 2021 | Apr 28, 2021 | Form 4 ↗ |
| FORMELA JEAN FRANCOISDirector | Sale | −806 | $84.93 | $68K | 1.1Mindirect | Apr 26, 2021 | Apr 28, 2021 | Form 4 ↗ |
| FORMELA JEAN FRANCOISDirector | Sale | −800 | $84.98 | $68K | 1.1Mindirect | Apr 5, 2021 | Apr 7, 2021 | Form 4 ↗ |
| DORSA CAROLINEDirector | Sale | −800 | $82.99 | $66K | 5,410direct | Apr 5, 2021 | Apr 6, 2021 | Form 4 ↗ |
| DORSA CAROLINEDirector | Sale | −4,686 | $82.35 | $386K | 6,210direct | Apr 5, 2021 | Apr 6, 2021 | Form 4 ↗ |
| DORSA CAROLINEDirector | Sale | −2,014 | $81.49 | $164K | 10.9Kdirect | Apr 5, 2021 | Apr 6, 2021 | Form 4 ↗ |
| LEONARD JOHN MPresident and CEO · Director | Sale | −13.9K | $83.00 | $1.2M | 693.4Kdirect | Apr 1, 2021 | Apr 2, 2021 | Form 4 ↗ |
| LEONARD JOHN MPresident and CEO · Director | Sale | −24.3K | $84.00 | $2.0M | 681.2Kdirect | Apr 1, 2021 | Apr 2, 2021 | Form 4 ↗ |
| Rivera Jose EEVP, General Counsel | Sale | −124 | $85.76 | $11K | 162.4Kdirect | Apr 1, 2021 | Apr 2, 2021 | Form 4 ↗ |
| Rivera Jose EEVP, General Counsel | Sale | −1,213 | $84.73 | $103K | 162.5Kdirect | Apr 1, 2021 | Apr 2, 2021 | Form 4 ↗ |
| Rivera Jose EEVP, General Counsel | Sale | −2,258 | $83.85 | $189K | 163.7Kdirect | Apr 1, 2021 | Apr 2, 2021 | Form 4 ↗ |
| Rivera Jose EEVP, General Counsel | Sale | −3,361 | $82.77 | $278K | 166.0Kdirect | Apr 1, 2021 | Apr 2, 2021 | Form 4 ↗ |
| Rivera Jose EEVP, General Counsel | Sale | −6,768 | $81.87 | $554K | 169.3Kdirect | Apr 1, 2021 | Apr 2, 2021 | Form 4 ↗ |
| Rivera Jose EEVP, General Counsel | Sale | −1,965 | $80.85 | $159K | 176.1Kdirect | Apr 1, 2021 | Apr 2, 2021 | Form 4 ↗ |
| Rivera Jose EEVP, General Counsel | Sale | −123 | $85.14 | $10K | 145.1Kdirect | Apr 1, 2021 | Apr 2, 2021 | Form 4 ↗ |
| Rivera Jose EEVP, General Counsel | Sale | −1,049 | $83.98 | $88K | 145.2Kdirect | Apr 1, 2021 | Apr 2, 2021 | Form 4 ↗ |
| Rivera Jose EEVP, General Counsel | Sale | −951 | $82.87 | $79K | 146.2Kdirect | Apr 1, 2021 | Apr 2, 2021 | Form 4 ↗ |
| Rivera Jose EEVP, General Counsel | Sale | −2,644 | $81.95 | $217K | 147.2Kdirect | Apr 1, 2021 | Apr 2, 2021 | Form 4 ↗ |
| Rivera Jose EEVP, General Counsel | Sale | −700 | $80.73 | $57K | 149.8Kdirect | Apr 1, 2021 | Apr 2, 2021 | Form 4 ↗ |
| Rivera Jose EEVP, General Counsel | Sale | −963 | $84.87 | $82K | 140.5Kdirect | Apr 1, 2021 | Apr 2, 2021 | Form 4 ↗ |
| Rivera Jose EEVP, General Counsel | Sale | −1,724 | $83.72 | $144K | 141.5Kdirect | Apr 1, 2021 | Apr 2, 2021 | Form 4 ↗ |
| Rivera Jose EEVP, General Counsel | Sale | −2,728 | $82.63 | $225K | 143.2Kdirect | Apr 1, 2021 | Apr 2, 2021 | Form 4 ↗ |
| Rivera Jose EEVP, General Counsel | Sale | −4,818 | $81.83 | $394K | 146.0Kdirect | Apr 1, 2021 | Apr 2, 2021 | Form 4 ↗ |
| Rivera Jose EEVP, General Counsel | Sale | −1,256 | $80.82 | $102K | 150.8Kdirect | Apr 1, 2021 | Apr 2, 2021 | Form 4 ↗ |
| Rivera Jose EEVP, General Counsel | Sale | −1,067 | $84.94 | $91K | 131.0Kdirect | Apr 1, 2021 | Apr 2, 2021 | Form 4 ↗ |
| Rivera Jose EEVP, General Counsel | Sale | −3,234 | $83.91 | $271K | 132.1Kdirect | Apr 1, 2021 | Apr 2, 2021 | Form 4 ↗ |
| Rivera Jose EEVP, General Counsel | Sale | −3,233 | $82.76 | $268K | 135.3Kdirect | Apr 1, 2021 | Apr 2, 2021 | Form 4 ↗ |
| Rivera Jose EEVP, General Counsel | Sale | −8,266 | $81.89 | $677K | 138.6Kdirect | Apr 1, 2021 | Apr 2, 2021 | Form 4 ↗ |
| Rivera Jose EEVP, General Counsel | Sale | −2,010 | $80.79 | $162K | 146.8Kdirect | Apr 1, 2021 | Apr 2, 2021 | Form 4 ↗ |
| FORMELA JEAN FRANCOISDirector | Sale | −501.9K | $60.29 | $30.3M | 1.1Mindirect | Feb 26, 2021 | Mar 1, 2021 | Form 4 ↗ |
| Rivera Jose EEVP, General Counsel | Sale | −11.5K | $75.00 | $862K | 117.9Kdirect | Feb 9, 2021 | Feb 9, 2021 | Form 4 ↗ |
| LEONARD JOHN MPresident and CEO · Director | Sale | −28.0K | $75.00 | $2.1M | 660.5Kdirect | Feb 9, 2021 | Feb 9, 2021 | Form 4 ↗ |
| LEONARD JOHN MPresident and CEO · Director | Sale | −881 | $68.78 | $61K | 631.9Kdirect | Feb 5, 2021 | Feb 9, 2021 | Form 4 ↗ |
| LEONARD JOHN MPresident and CEO · Director | Sale | −14.0K | $67.86 | $951K | 632.7Kdirect | Feb 5, 2021 | Feb 9, 2021 | Form 4 ↗ |
| LEONARD JOHN MPresident and CEO · Director | Sale | −8,043 | $67.18 | $540K | 646.8Kdirect | Feb 5, 2021 | Feb 9, 2021 | Form 4 ↗ |
| LEONARD JOHN MPresident and CEO · Director | Sale | −36.9K | $73.00 | $2.7M | 614.8Kdirect | Feb 3, 2021 | Feb 3, 2021 | Form 4 ↗ |
| LEONARD JOHN MPresident and CEO · Director | Sale | −31.0K | $72.00 | $2.2M | 584.6Kdirect | Feb 3, 2021 | Feb 3, 2021 | Form 4 ↗ |
| LEONARD JOHN MPresident and CEO · Director | Sale | −5,475 | $65.04 | $356K | 565.6Kdirect | Feb 1, 2021 | Feb 3, 2021 | Form 4 ↗ |
| LEONARD JOHN MPresident and CEO · Director | Sale | −16.6K | $64.10 | $1.1M | 571.1Kdirect | Feb 1, 2021 | Feb 3, 2021 | Form 4 ↗ |
| LEONARD JOHN MPresident and CEO · Director | Sale | −11.1K | $63.30 | $703K | 587.7Kdirect | Feb 1, 2021 | Feb 3, 2021 | Form 4 ↗ |
| LEONARD JOHN MPresident and CEO · Director | Sale | −3,260 | $65.03 | $212K | 538.8Kdirect | Feb 1, 2021 | Feb 3, 2021 | Form 4 ↗ |
| LEONARD JOHN MPresident and CEO · Director | Sale | −9,432 | $64.09 | $604K | 542.1Kdirect | Feb 1, 2021 | Feb 3, 2021 | Form 4 ↗ |
| LEONARD JOHN MPresident and CEO · Director | Sale | −6,448 | $63.29 | $408K | 551.5Kdirect | Feb 1, 2021 | Feb 3, 2021 | Form 4 ↗ |
| LEONARD JOHN MPresident and CEO · Director | Sale | −693 | $65.02 | $45K | 528.0Kdirect | Feb 1, 2021 | Feb 3, 2021 | Form 4 ↗ |
| LEONARD JOHN MPresident and CEO · Director | Sale | −3,497 | $64.16 | $224K | 528.6Kdirect | Feb 1, 2021 | Feb 3, 2021 | Form 4 ↗ |
| LEONARD JOHN MPresident and CEO · Director | Sale | −1,709 | $63.24 | $108K | 532.1Kdirect | Feb 1, 2021 | Feb 3, 2021 | Form 4 ↗ |
| LEONARD JOHN MPresident and CEO · Director | Sale | −8,827 | $65.00 | $574K | 523.9Kdirect | Feb 1, 2021 | Feb 3, 2021 | Form 4 ↗ |
| LEONARD JOHN MPresident and CEO · Director | Sale | −26.1K | $64.13 | $1.7M | 532.7Kdirect | Feb 1, 2021 | Feb 3, 2021 | Form 4 ↗ |
| LEONARD JOHN MPresident and CEO · Director | Sale | −16.8K | $63.32 | $1.1M | 558.7Kdirect | Feb 1, 2021 | Feb 3, 2021 | Form 4 ↗ |
| Rivera Jose EEVP, General Counsel | Sale | −755 | $65.07 | $49K | 108.4Kdirect | Feb 1, 2021 | Feb 3, 2021 | Form 4 ↗ |
| Rivera Jose EEVP, General Counsel | Sale | −2,386 | $64.18 | $153K | 109.2Kdirect | Feb 1, 2021 | Feb 3, 2021 | Form 4 ↗ |
| Rivera Jose EEVP, General Counsel | Sale | −2,326 | $63.44 | $148K | 111.5Kdirect | Feb 1, 2021 | Feb 3, 2021 | Form 4 ↗ |
| Rivera Jose EEVP, General Counsel | Sale | −2,827 | $65.05 | $184K | 103.9Kdirect | Feb 1, 2021 | Feb 3, 2021 | Form 4 ↗ |
| Rivera Jose EEVP, General Counsel | Sale | −8,366 | $64.16 | $537K | 106.7Kdirect | Feb 1, 2021 | Feb 3, 2021 | Form 4 ↗ |
| Rivera Jose EEVP, General Counsel | Sale | −6,617 | $63.34 | $419K | 115.1Kdirect | Feb 1, 2021 | Feb 3, 2021 | Form 4 ↗ |
| Rivera Jose EEVP, General Counsel | Sale | −5,312 | $65.01 | $345K | 88.7Kdirect | Feb 1, 2021 | Feb 3, 2021 | Form 4 ↗ |
| Rivera Jose EEVP, General Counsel | Sale | −15.6K | $64.11 | $1.0M | 94.0Kdirect | Feb 1, 2021 | Feb 3, 2021 | Form 4 ↗ |
| Rivera Jose EEVP, General Counsel | Sale | −10.5K | $63.31 | $663K | 109.6Kdirect | Feb 1, 2021 | Feb 3, 2021 | Form 4 ↗ |
| LEONARD JOHN MPresident and CEO · Director | Sale | −6,239 | $55.86 | $349K | 475.5Kdirect | Jan 5, 2021 | Jan 5, 2021 | Form 4 ↗ |
| SCHIERMEIER ANDREWEVP, Chief Operating Officer | Sale | −1,377 | $55.86 | $77K | 16.7Kdirect | Jan 5, 2021 | Jan 5, 2021 | Form 4 ↗ |
| Rivera Jose EEVP, General Counsel | Sale | −2,078 | $55.86 | $116K | 52.0Kdirect | Jan 5, 2021 | Jan 5, 2021 | Form 4 ↗ |
| KARSEN PERRY ADirector | Sale | −21.3K | $54.33 | $1.2M | 5,000direct | Dec 17, 2020 | Dec 18, 2020 | Form 4 ↗ |
| KARSEN PERRY ADirector | Sale | −45.5K | $53.69 | $2.4M | 26.3Kdirect | Dec 17, 2020 | Dec 18, 2020 | Form 4 ↗ |
| KARSEN PERRY ADirector | Sale | −22.0K | $52.52 | $1.2M | 71.8Kdirect | Dec 17, 2020 | Dec 18, 2020 | Form 4 ↗ |
| Rivera Jose EEVP, General Counsel | Sale | −257 | $39.46 | $10K | 48.7Kdirect | Dec 1, 2020 | Dec 3, 2020 | Form 4 ↗ |
| Rivera Jose EEVP, General Counsel | Sale | −1,522 | $38.49 | $59K | 49.0Kdirect | Dec 1, 2020 | Dec 3, 2020 | Form 4 ↗ |
| Rivera Jose EEVP, General Counsel | Sale | −1,585 | $37.73 | $60K | 50.5Kdirect | Dec 1, 2020 | Dec 3, 2020 | Form 4 ↗ |
| LEONARD JOHN MPresident and CEO · Director | Sale | −20.0K | $39.00 | $780K | 467.4Kdirect | Nov 27, 2020 | Nov 27, 2020 | Form 4 ↗ |
| LEONARD JOHN MPresident and CEO · Director | Sale | −15.0K | $38.00 | $570K | 467.4Kdirect | Nov 27, 2020 | Nov 27, 2020 | Form 4 ↗ |
| LEONARD JOHN MPresident and CEO · Director | Sale | −50.0K | $36.00 | $1.8M | 467.4Kdirect | Nov 25, 2020 | Nov 25, 2020 | Form 4 ↗ |
| Rivera Jose EEVP, General Counsel | Sale | −624 | $35.00 | $22K | 47.1Kdirect | Nov 18, 2020 | Nov 18, 2020 | Form 4 ↗ |
| LEONARD JOHN MPresident and CEO · Director | Sale | −20.0K | $34.00 | $680K | 467.4Kdirect | Nov 16, 2020 | Nov 18, 2020 | Form 4 ↗ |
| Rivera Jose EEVP, General Counsel | Sale | −414 | $35.00 | $14K | 46.8Kdirect | Nov 16, 2020 | Nov 18, 2020 | Form 4 ↗ |
| Rivera Jose EEVP, General Counsel | Sale | −3,595 | $34.51 | $124K | 46.7Kdirect | Nov 16, 2020 | Nov 18, 2020 | Form 4 ↗ |
| Rivera Jose EEVP, General Counsel | Sale | −2,020 | $33.75 | $68K | 50.3Kdirect | Nov 16, 2020 | Nov 18, 2020 | Form 4 ↗ |
| Rivera Jose EEVP, General Counsel | Sale | −3,364 | $28.00 | $94K | 42.3Kdirect | Nov 4, 2020 | Nov 6, 2020 | Form 4 ↗ |
| LEONARD JOHN MPresident and CEO · Director | Sale | −50.0K | $26.00 | $1.3M | 467.4Kdirect | Nov 4, 2020 | Nov 6, 2020 | Form 4 ↗ |
| Rivera Jose EEVP, General Counsel | Sale | −156 | $24.55 | $4K | 40.7Kdirect | Oct 15, 2020 | Oct 16, 2020 | Form 4 ↗ |
| Rivera Jose EEVP, General Counsel | Sale | −5,459 | $24.19 | $132K | 40.8Kdirect | Oct 15, 2020 | Oct 16, 2020 | Form 4 ↗ |
| LEONARD JOHN MPresident and CEO · Director | Sale | −5,000 | $21.83 | $109K | 467.4Kdirect | Oct 7, 2020 | Oct 9, 2020 | Form 4 ↗ |
| Rivera Jose EEVP, General Counsel | Sale | −5,615 | $21.04 | $118K | 36.3Kdirect | Sep 15, 2020 | Sep 17, 2020 | Form 4 ↗ |
| LEONARD JOHN M.President and CEO · Director | Sale | −5,000 | $21.83 | $109K | 467.4Kdirect | Sep 1, 2020 | Sep 3, 2020 | Form 4 ↗ |
| Rivera Jose EEVP, General Counsel | Sale | −5,615 | $21.00 | $118K | 31.9Kdirect | Aug 18, 2020 | Aug 20, 2020 | Form 4 ↗ |
| LEONARD JOHN M.President and CEO · Director | Sale | −5,000 | $21.83 | $109K | 467.4Kdirect | Aug 6, 2020 | Aug 7, 2020 | Form 4 ↗ |
| Rivera Jose EEVP, General Counsel | Sale | −5,615 | $22.70 | $127K | 27.5Kdirect | Jul 15, 2020 | Jul 17, 2020 | Form 4 ↗ |
| LEONARD JOHN M.President and CEO · Director | Sale | −5,000 | $21.83 | $109K | 467.4Kdirect | Jul 1, 2020 | Jul 2, 2020 | Form 4 ↗ |
| Rivera Jose EEVP, General Counsel | Sale | −5,615 | $21.00 | $118K | 22.3Kdirect | Jun 16, 2020 | Jun 18, 2020 | Form 4 ↗ |
| LEONARD JOHN M.President and CEO · Director | Sale | −5,000 | $21.83 | $109K | 467.4Kdirect | Jun 3, 2020 | Jun 5, 2020 | Form 4 ↗ |
| Rivera Jose EEVP, General Counsel | Sale | −5,615 | $21.21 | $119K | 280.1Kdirect | May 26, 2020 | May 28, 2020 | Form 4 ↗ |
| SCHIERMEIER ANDREWEVP, Dev and Corp Strategy | Purchase | +4,250 | $15.50 | $66K | 7,500direct | Mar 6, 2019 | Mar 12, 2019 | Form 4 ↗ |
| SCHIERMEIER ANDREWEVP, Dev and Corp Strategy | Purchase | +3,250 | $16.00 | $52K | 3,250direct | Mar 6, 2019 | Mar 12, 2019 | Form 4 ↗ |
| FORMELA JEAN FRANCOISDirector | Sale | −1,402 | $31.93 | $45K | 0indirect | Jul 16, 2018 | Jul 18, 2018 | Form 4 ↗ |
| FORMELA JEAN FRANCOISDirector | Sale | −5,284 | $30.97 | $164K | 1,402indirect | Jul 16, 2018 | Jul 18, 2018 | Form 4 ↗ |
| FORMELA JEAN FRANCOISDirector | Sale | −1,400 | $28.39 | $40K | 0indirect | Jun 19, 2018 | Jun 20, 2018 | Form 4 ↗ |
| FORMELA JEAN FRANCOISDirector | Sale | −5,286 | $27.84 | $147K | 1,400indirect | Jun 19, 2018 | Jun 20, 2018 | Form 4 ↗ |
| FORMELA JEAN FRANCOISDirector | Sale | −6,686 | $25.04 | $167K | 0indirect | May 16, 2018 | May 17, 2018 | Form 4 ↗ |
| LEONARD JOHN M.President and CEO · Director | Sale | −8,400 | $24.00 | $202K | 0indirect | May 14, 2018 | May 15, 2018 | Form 4 ↗ |
| FORMELA JEAN FRANCOISDirector | Sale | −36.6K | $23.78 | $871K | 0indirect | Mar 20, 2018 | Mar 22, 2018 | Form 4 ↗ |
| FORMELA JEAN FRANCOISDirector | Sale | −2,617 | $25.06 | $66K | 36.6Kindirect | Mar 20, 2018 | Mar 22, 2018 | Form 4 ↗ |
| Caribou Biosciences, Inc.10% owner | Sale | −550.6K | $26.78 | $14.7M | 4.0Mindirect | Jan 29, 2018 | Jan 30, 2018 | Form 4 ↗ |
| Novartis Institutes for BioMedical Research, Inc.10% owner | Sale | −1.5M | $18.30 | $27.9M | 4.1Mdirect | Dec 12, 2017 | Dec 14, 2017 | Form 4 ↗ |
| Bermingham NessanPresident & CEO · Director | Sale | −94.1K | $20.82 | $2.0M | 458.3Kdirect | Dec 8, 2017 | Dec 8, 2017 | Form 4 ↗ |
| Bermingham NessanPresident & CEO · Director | Sale | −27.6K | $21.46 | $592K | 552.4Kdirect | Dec 7, 2017 | Dec 8, 2017 | Form 4 ↗ |
| Bermingham NessanPresident & CEO · Director | Sale | −103.6K | $21.05 | $2.2M | 580.0Kdirect | Dec 7, 2017 | Dec 8, 2017 | Form 4 ↗ |
| Bermingham NessanPresident & CEO · Director | Sale | −12.5K | $20.84 | $260K | 683.5Kdirect | Dec 6, 2017 | Dec 8, 2017 | Form 4 ↗ |
| Bermingham NessanPresident & CEO · Director | Sale | −99.0K | $20.28 | $2.0M | 696.0Kdirect | Dec 6, 2017 | Dec 8, 2017 | Form 4 ↗ |
| Caribou Biosciences, Inc.10% owner | Sale | −1.0M | — | — | 4.5Mindirect | Sep 13, 2017 | Sep 13, 2017 | Form 4 ↗ |
| FORMELA JEAN FRANCOISDirector | Sale | −80.0K | $16.07 | $1.3M | 3.6Mindirect | Jul 11, 2017 | Jul 11, 2017 | Form 4 ↗ |
| Atlas Venture Associates IX, L.P.10% owner | Sale | −80.0K | $16.07 | $1.3M | 3.6Mdirect | Jul 11, 2017 | Jul 11, 2017 | Form 4 ↗ |
| FORMELA JEAN FRANCOISDirector | Sale | −40.0K | $16.17 | $647K | 3.7Mindirect | Jul 10, 2017 | Jul 11, 2017 | Form 4 ↗ |
| Atlas Venture Associates IX, L.P.10% owner | Sale | −40.0K | $16.17 | $647K | 3.7Mdirect | Jul 10, 2017 | Jul 11, 2017 | Form 4 ↗ |
| FORMELA JEAN FRANCOISDirector | Sale | −30.0K | $16.77 | $503K | 3.7Mindirect | Jul 7, 2017 | Jul 11, 2017 | Form 4 ↗ |
| Atlas Venture Associates IX, L.P.10% owner | Sale | −30.0K | $16.77 | $503K | 3.7Mdirect | Jul 7, 2017 | Jul 11, 2017 | Form 4 ↗ |
| Atlas Venture Associates IX, L.P.10% owner | Sale | −5,504 | $14.06 | $77K | 0direct | Mar 10, 2017 | Mar 13, 2017 | Form 4 ↗ |
| FORMELA JEAN FRANCOISDirector | Sale | −5,504 | $14.06 | $77K | 0indirect | Mar 10, 2017 | Mar 13, 2017 | Form 4 ↗ |
| Atlas Venture Associates IX, L.P.10% owner | Sale | −15.6K | $13.85 | $216K | 5,504direct | Mar 9, 2017 | Mar 13, 2017 | Form 4 ↗ |
| FORMELA JEAN FRANCOISDirector | Sale | −15.6K | $13.85 | $216K | 5,504indirect | Mar 9, 2017 | Mar 13, 2017 | Form 4 ↗ |
| ISALY SAMUEL DDirector | Purchase | +58.5K | n/c | — | 2.7Mindirect | May 11, 2016 | May 13, 2016 | Form 4 ↗ |
| ISALY SAMUEL DDirector | Purchase | +191.5K | n/c | — | 2.6Mindirect | May 11, 2016 | May 13, 2016 | Form 4 ↗ |
| Temasek Holdings (Private) Ltd10% owner | Purchase | +300.0K | n/c | — | 790.5Kindirect | May 11, 2016 | May 13, 2016 | Form 4 ↗ |
| BAKER JULIAN | Purchase | +179.5K | n/c | — | 976.2Kindirect | May 11, 2016 | May 11, 2016 | Form 4 ↗ |
| BAKER JULIAN | Purchase | +20.5K | n/c | — | 85.9Kindirect | May 11, 2016 | May 11, 2016 | Form 4 ↗ |
| Novartis Institutes for BioMedical Research, Inc.10% owner | Purchase | +277.8K | n/c | — | 5.6Mdirect | May 11, 2016 | May 11, 2016 | Form 4 ↗ |
| GORDON CARL LDirector | Purchase | +58.5K | n/c | — | 2.7Mindirect | May 11, 2016 | May 11, 2016 | Form 4 ↗ |
| GORDON CARL LDirector | Purchase | +191.5K | n/c | — | 2.6Mindirect | May 11, 2016 | May 11, 2016 | Form 4 ↗ |
Source: SEC EDGAR Form 4 and Form 5 filings, SEC's quarterly bulk dataset through Jun 30, 2026, and KeyVex's half-hourly read of new filings since. Every row links its filing. Amendments are marked. Nothing here is a recommendation. All insider activity, market-wide →